Michael Medici
Summit Partners
Managing Director
Boston, Massachusetts

()

Category: Mid/Large Cap
Mark: AA

Comments are closed.

Biography

As a Managing Director on Summit Partners’ Technology Team, Michael draws on more than two decades of experience investing in high-growth companies across the technology landscape. Since joining the firm in 2005, he has built deep sector expertise within several software subsectors, including e-commerce enablement, marketing automation, infrastructure and DevOps, industrial technology, and supply chain. In total, Michael has led or played a significant role in 20 Summit investments, representing more than $1.3 billion in invested capital.


Michael is an active, engaged board member at several Summit portfolio companies. He currently serves on the boards of Fundraise Up, Klaviyo (NYSE: KVYO), Later, MacStadium, Vestmark, and Sifted. His prior investments and directorships include Acacia Communications (NASDAQ: ACIA, later acquired by Cisco), Accedian Networks (acquired by Bridge Growth Partners), Anesthetix (acquired by TeamHealth), Clarabridge (acquired by Qualtrics), Diagnostic Hybrids (acquired by Quidel Corporation), Fermentas International (acquired by Thermo Fisher Scientific), Hiperos (acquired by Opus Global), Logi Analytics (acquired by Marlin Equity Partners), Mi9 Retail (acquired by General Atlantic), and Telerik (acquired by Progress Software).


Awards

Top Software Investors: 2025, 2024, 2023, 2022